Načítá se...
IGHV Mutational Status Testing in Chronic Lymphocytic Leukemia
As the therapeutic landscape for chronic lymphocytic leukemia (CLL) continues to expand, biological predictors of response to therapy are becoming increasingly important. One such predictive biomarker is the mutational status of the variable region of the immunoglobulin heavy chain (IGHV) gene, whic...
Uloženo v:
| Vydáno v: | Am J Hematol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675754/ https://ncbi.nlm.nih.gov/pubmed/28589701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24808 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|